Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 32 Issue 9, September 2025

Ubiquitin and protein degradation

In this Focus issue, we highlight primary research and commissioned content about ubiquitylation and protein degradation mechanisms. Our cover features a school of fish evoking the barrel-shaped proteasome.

See Editorial

Image credit: Kittisun Kittayacharoenpong / Moment / Getty images. Cover design: Allen Beattie

Editorial

  • Advertisement

Top of page ⤴

Comment

  • Post-translational modifications show mechanistic crosstalk, exemplified by the ADP-ribose–ubiquitin hybrid signal, in which one post-translational modification modifies another. This Comment highlights its discovery, mechanistic basis and functional consequences, and outlines critical questions for understanding this emerging signaling paradigm.

    • Chatrin Chatrin
    • Kang Zhu
    • Ivan Ahel
    Comment
Top of page ⤴

News & Views

  • A recent high-resolution structure of USP30 bound to a selective inhibitor identifies a cryptic binding pocket formed through a conformational switch in the catalytic domain of the enzyme. This mechanistic insight opens a door to structure-guided design of mitophagy-enhancing compounds.

    • Julia C. Fitzgerald
    • Anja Bremm
    News & Views
  • Centrosomal protein assemblies can lead to mitotic spindle dysfunction and abnormal cell division. Two studies published in this issue unveil the molecular choreography orchestrated by TRIM37 in blocking the accumulation of these structures in a remarkable fashion that resembles viral capsid recognition.

    • Renata Basto
    News & Views
Top of page ⤴

Research Briefings

  • A new class of small molecular ‘glues’ selectively inhibit the BRISC deubiquitylase complex by stabilizing it in an inactive dimeric conformation. These compounds reduce inflammatory signaling by preventing deubiquitylation of an interferon receptor, and thereby offer a promising avenue for the treatment of type I interferon-driven diseases.

    Research Briefing
  • The Pro/N-degron E3 ligase GID4 can be harnessed for proteolysis-targeting chimera (PROTAC) applications, as demonstrated by a GID4-based bromodomain-containing protein 4 (BRD4)-targeting PROTAC, which inhibits cell proliferation and exhibits antitumor activity. Structural analysis of the GID4–PROTAC–BRD4 ternary complexes reveals plasticity in the underlying interactions, providing valuable insights into the degradation mechanism.

    Research Briefing
Top of page ⤴

Articles

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links